A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma

Figure 4

Nomogram and independent prognostic analysis. (a–d) The univariate and multivariate Cox regression analyses of the lncRNA signature and other clinical characteristics associated with OS in the training cohort and validation set. (e, f) The nomogram and calibration curves for predicting the probability of the 1-, 2-, and 3-year OS.

(a)

(b)

(c)

(d)

(e)

(f)